NEBILET

This brand name is authorized in Australia, Brazil, Germany, Ecuador, Estonia, Hong Kong, Ireland, Lithuania, Malta, Netherlands, Poland, Romania, Singapore, Tunisia, United Kingdom, South Africa

Active ingredients

The drug NEBILET contains one active pharmaceutical ingredient (API):

1 Nebivolol
UNII JGS34J7L9I - NEBIVOLOL HYDROCHLORIDE

Nebivolol is a racemate of two enantiomers, SRRR-nebivolol (or d-nebivolol) and RSSS-nebivolol (or l-nebivolol). It is a competitive and selective beta-receptor antagonist and it has mild vasodilating properties due to an interaction with the L-arginine/nitric oxide pathway.

Read about Nebivolol

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
NEBILET Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C07AB12 Nebivolol C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 9311C, 9312D, 9316H
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 504114004115313, 504114008110316, 504116020054503, 504116020054603, 504116020054703
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 07371053, 07371076, 07371082, 10039701, 10172920, 13595816
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 363661212
Country: EE Ravimiamet Identifier(s): 1032297, 1072426, 1072437, 1445116, 1445127, 1445138, 1445149, 1445150, 1880210, 1880221, 1880232, 1880243, 1880254, 1880265, 1880276, 1880287
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 139361, 143301, 16158, 162117, 373485
Country: HK Department of Health Drug Office Identifier(s): 59922, 65104
Country: IE Health Products Regulatory Authority Identifier(s): 35608, 35653, 54373
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1003103, 1005010, 1005395, 1011147, 1011148, 1051639, 1051640, 1051641, 1051643
Country: MT Medicines Authority Identifier(s): MA204/00201
Country: NL Z-Index G-Standaard, PRK Identifier(s): 46353
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100084850
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W04501001, W04501002, W04501003, W04501004, W04501005, W04501006
Country: SG Health Sciences Authority Identifier(s): 11728P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 15463013
Country: ZA Health Products Regulatory Authority Identifier(s): 34/7.1.3/0495

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.